Senthil Anand, Hilmi Alnsasra, Lisa M LeMond, Sanskriti Shrivastava, Rabea Asleh, Andrew Rosenbaum, Semaan Kobrossi, Akanksha Mohananey, Katie Murphy, Byron H Smith, Sudhir Kushwaha, David E Steidley, Alfredo Clavell, Phillip Young, Naveen L Pereira
AIMS: Graft dysfunction (GD) after heart transplantation (HTx) can develop without evidence of cell- or antibody-mediated rejection. Cardiac magnetic resonance imaging (CMR) has an evolving role in detecting rejection; however, its role in biopsy-negative GD has not been described. This study examines CMR findings, evaluates outcomes based on CMR results, and seeks to identify the possibility of rejection missed through endomyocardial biopsy by using CMR in HTx recipients with biopsy-negative GD...
February 20, 2024: ESC Heart Failure